
About this episode
M&A processes can vary from country to country, making cross-border deals extremely challenging. Understanding the cultural differences is crucial for a smooth transaction.
In this episode of the M&A Science Podcast, we focus on how to do M&A deals in Germany, featuring Frank Tepper-Sawicki, Partner, Corporate M&A, Private Equity, and Venture Capital at Dentons.
Things you will learn:
• How dealmaking is different in Germany
• Structuring Deals in Germany
• Letter of Intent in Germany
• Prioritizations during deals in Germany
• Regulatory issues in Germany
This episode is sponsored by the DealRoom
Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at https://dealroom.net
******************
Episode Timestamps
00:00 Intro
03:49 How dealmaking is different in Germany
05:48 Private Equity Emerging in Germany
07:47 Structuring Deals in Germany
16:33 Letter of Intent in Germany
22:11 Prioritizations during deals in Germany
24:59 Transparency in Germany
26:17 Regulatory issues in Germany
28:17 Laying off people in Germany
30:15 Biggest risk when doing deals in Germany
32:43 M&A culture in Germany
35:00 Dealing with people from Germany
37:28 M&A process in Germany
39:18 Craziest thing in M&A
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science

Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science

Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science

Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science

Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science